Paper34623971
Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer.
Fan X and 5 others. Aging (Albany NY), 2021. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer. Papers, record 34623971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34623971
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ginsenosides | Major topic |
| Janus Kinase 2 | Major topic |
| Pancreatic Neoplasms | Major topic |
| STAT3 Transcription Factor | Major topic |
| Signal Transduction | Major topic |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Humans | |
| Models, Molecular | |
| Molecular Structure |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15620274 | The role of natural product chemistry in drug discovery. | J Nat Prod | 2004 | https://conductscience.org/library/papers/15620274 | PubMed |
| 2 | 28375170 | Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28375170 | PubMed |
| 3 | 33433946 | Cancer Statistics, 2021. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33433946 | PubMed |
| 4 | 30344279 | Chemotherapy in Pancreatic Cancer: A Systematic Review. | Medicina (Kaunas) | 2018 | https://conductscience.org/library/papers/30344279 | PubMed |
| 5 | 25220761 | MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2. | Oncol Rep | 2014 | https://conductscience.org/library/papers/25220761 | PubMed |
| 6 | 25098340 | Dual-inhibitors of STAT5 and STAT3: studies from molecular docking and molecular dynamics simulations. | J Mol Model | 2014 | https://conductscience.org/library/papers/25098340 | PubMed |
| 7 | 26646273 | Blockage of STAT3 Signaling Pathway by Morusin Induces Apoptosis and Inhibits Invasion in Human Pancreatic Tumor Cells. | Pancreas | 2016 | https://conductscience.org/library/papers/26646273 | PubMed |
| 8 | 8142617 | Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. | Semin Cancer Biol | 1993 | https://conductscience.org/library/papers/8142617 | PubMed |
| 9 | 25427123 | Pancreatic adenocarcinoma. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25427123 | PubMed |
| 10 | 32702511 | Novel panaxadiol triazole derivatives induce apoptosis in HepG-2 cells through the mitochondrial pathway. | Bioorg Chem | 2020 | https://conductscience.org/library/papers/32702511 | PubMed |
| 11 | 16921264 | What are caspases 3 and 7 doing upstream of the mitochondria? | Cancer Biol Ther | 2006 | https://conductscience.org/library/papers/16921264 | PubMed |
| 12 | 22403544 | Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure-Activity Relationships, and Molecular Mechanisms of Action. | Front Pharmacol | 2012 | https://conductscience.org/library/papers/22403544 | PubMed |
| 13 | 15317546 | Modern management of pancreatic carcinoma. | Intern Med J | 2004 | https://conductscience.org/library/papers/15317546 | PubMed |
| 14 | 26830752 | Pancreatic cancer. | Lancet | 2016 | https://conductscience.org/library/papers/26830752 | PubMed |
| 15 | 23115069 | The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours. | Endokrynol Pol | 2012 | https://conductscience.org/library/papers/23115069 | PubMed |
| 16 | 28266999 | Combination of Panaxadiol and Panaxatriol Type Saponins and Ophioponins From Shenmai Formula Attenuates Lipopolysaccharide-induced Inflammatory Injury in Cardiac Microvascular Endothelial Cells by Blocking NF-kappa B Pathway. | J Cardiovasc Pharmacol | 2017 | https://conductscience.org/library/papers/28266999 | PubMed |
| 17 | 32203277 | Targeting apoptosis in cancer therapy. | Nat Rev Clin Oncol | 2020 | https://conductscience.org/library/papers/32203277 | PubMed |
| 18 | 9671298 | Three-dimensional structure of the Stat3beta homodimer bound to DNA. | Nature | 1998 | https://conductscience.org/library/papers/9671298 | PubMed |
| 19 | 33029256 | High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma. | Dis Markers | 2020 | https://conductscience.org/library/papers/33029256 | PubMed |
| 20 | 16619368 | In Vivo radioprotective effect of Panax ginseng C.A. Meyer and identification of active ginsenosides. | Phytother Res | 2006 | https://conductscience.org/library/papers/16619368 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42450802 | Selenium Attenuates LPS-Induced Injury in Ovine Granulosa Cells by Protecting Mitochondrial Ultrastructure and Cellular Homeostasis. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42450802 | PubMed |
| 42083988 | Integrating QSAR-Machine Learning, Biochemical Assays, and Molecular Dynamics for the Discovery of JAK2 Inhibitors in Cervical Cancer. | J Chem Inf Model | 2026 | https://conductscience.org/library/papers/42083988 | PubMed |
| 40895287 | Exploring novel furochochicine derivatives as promising JAK2 inhibitors in HeLa cells: Integrating docking, QSAR-ML, MD simulations, and experiments. | Comput Struct Biotechnol J | 2025 | https://conductscience.org/library/papers/40895287 | PubMed |
| 40452916 | Integrating network pharmacology and experimental validation to reveal the anti-growth mechanism of panaxadiol against glioblastoma via calcium signaling. | Front Mol Biosci | 2025 | https://conductscience.org/library/papers/40452916 | PubMed |
| 40061598 | Network pharmacology and in vivo study: Unraveling the therapeutic mechanisms of Panax ginseng in potentially treating ulcerative colitis. | World J Gastroenterol | 2025 | https://conductscience.org/library/papers/40061598 | PubMed |
| 39720955 | JAK2 inactivating mutations promotes endometrial cancer progression by targeting HIF-1α. | Discov Oncol | 2024 | https://conductscience.org/library/papers/39720955 | PubMed |
| 39440734 | Potential Anti-tumor Effects and Apoptosis-inducing Mechanisms of Saponins: A Review. | Curr Top Med Chem | 2025 | https://conductscience.org/library/papers/39440734 | PubMed |
| 38706884 | Potential JAK2 Inhibitors from Selected Natural Compounds: A Promising Approach for Complementary Therapy in Cancer Patients. | Evid Based Complement Alternat Med | 2024 | https://conductscience.org/library/papers/38706884 | PubMed |
| 38464736 | Role of STAT3 in pancreatic cancer. | Explor Target Antitumor Ther | 2024 | https://conductscience.org/library/papers/38464736 | PubMed |
| 38252208 | Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the JAK2/STAT3 pathway. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38252208 | PubMed |
| 37958803 | DLGAP5 Regulates the Proliferation, Migration, Invasion, and Cell Cycle of Breast Cancer Cells via the JAK2/STAT3 Signaling Axis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958803 | PubMed |
| 36814203 | FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma. | BMC Cancer | 2023 | https://conductscience.org/library/papers/36814203 | PubMed |
| 36500220 | Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. | Molecules | 2022 | https://conductscience.org/library/papers/36500220 | PubMed |
| 36313365 | Research progress of ginseng in the treatment of gastrointestinal cancers. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36313365 | PubMed |
| 36188592 | Inhibitory effects of total triterpenoids isolated from the Hedyotis diffusa willd on H1975 cells. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36188592 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34623971
GET https://conductscience.org/api/papers/v1/34623971/references?page=2